• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nocturia in Parkinson's Disease: Why Does It Occur and How to Manage?帕金森病中的夜尿症:为何会发生以及如何处理?
Mov Disord Clin Pract. 2016 Jun 7;3(5):443-451. doi: 10.1002/mdc3.12374. eCollection 2016 Sep-Oct.
2
Nocturia in Patients With Parkinson's Disease.帕金森病患者的夜尿症
Mov Disord Clin Pract. 2015 Dec 24;3(2):168-172. doi: 10.1002/mdc3.12279. eCollection 2016 Mar-Apr.
3
Treatment Options for Urogenital Dysfunction in Parkinson's Disease.帕金森病泌尿生殖功能障碍的治疗选择
Curr Treat Options Neurol. 2016 Oct;18(10):45. doi: 10.1007/s11940-016-0427-0.
4
Nocturnal polyuria and nocturia.夜间多尿和夜尿症。
Int Urol Nephrol. 2023 Jun;55(6):1395-1401. doi: 10.1007/s11255-023-03582-5. Epub 2023 Mar 31.
5
Nocturia夜尿症
6
Management Strategies for Nocturia.夜尿症的管理策略。
Curr Urol Rep. 2019 Nov 9;20(11):75. doi: 10.1007/s11934-019-0940-2.
7
Diagnostic and therapeutic recommendations for patients with nocturia.夜尿症患者的诊断和治疗建议。
Cent European J Urol. 2017;70(4):388-393. doi: 10.5173/ceju.2017.1563. Epub 2017 Sep 25.
8
[Diagnostic and therapeutic approach to nocturia in Primary Care].[基层医疗中夜尿症的诊断与治疗方法]
Semergen. 2020 Oct;46(7):487-496. doi: 10.1016/j.semerg.2020.03.002. Epub 2020 May 25.
9
Pharmacotherapeutic options in the treatment of nocturia: an update on the current oral drug therapies.治疗夜间多尿症的药物治疗选择:当前口服药物治疗的最新进展。
Expert Opin Pharmacother. 2022 Feb;23(3):405-411. doi: 10.1080/14656566.2021.2016698. Epub 2021 Dec 15.
10
Pathophysiological aspects of nocturia in a danish population of men and women age 60 to 80 years.丹麦60至80岁男性和女性夜尿症的病理生理方面
J Urol. 2007 Aug;178(2):552-7. doi: 10.1016/j.juro.2007.03.141. Epub 2007 Jun 14.

引用本文的文献

1
A reset on our reclined position-a call to prioritize neurogenic supine hypertension in the synucleinopathies.对我们卧位姿势的重新审视——呼吁在突触核蛋白病中优先关注神经源性仰卧位高血压。
Clin Auton Res. 2025 Jun 18. doi: 10.1007/s10286-025-01140-w.
2
Post hoc exploratory analysis of the effect of foslevodopa/foscarbidopa continuous subcutaneous infusion on nocturia in patients with Parkinson's disease.左旋多巴/卡比多巴连续皮下输注对帕金森病患者夜尿症影响的事后探索性分析。
Clin Park Relat Disord. 2025 Apr 26;12:100330. doi: 10.1016/j.prdoa.2025.100330. eCollection 2025.
3
Circadian rhythm disruption: a potential trigger in Parkinson's disease pathogenesis.昼夜节律紊乱:帕金森病发病机制中的一个潜在触发因素。
Front Cell Neurosci. 2024 Oct 30;18:1464595. doi: 10.3389/fncel.2024.1464595. eCollection 2024.
4
Insomnia in Parkinson's Disease: Causes, Consequences, and Therapeutic Approaches.帕金森病中的失眠:病因、后果及治疗方法
Mol Neurobiol. 2025 Feb;62(2):2292-2313. doi: 10.1007/s12035-024-04400-4. Epub 2024 Aug 5.
5
Impact of deep brain stimulation on urogenital function in Parkinson's disease: a systematic review and meta-analysis.深部脑刺激对帕金森病泌尿生殖功能的影响:一项系统评价和荟萃分析。
Front Neurol. 2024 Jul 4;15:1397344. doi: 10.3389/fneur.2024.1397344. eCollection 2024.
6
Impact of Safinamide on Patient-Reported Outcomes in Parkinson's Disease.沙芬酰胺对帕金森病患者报告结局的影响。
Patient Relat Outcome Meas. 2023 Oct 10;14:285-295. doi: 10.2147/PROM.S369590. eCollection 2023.
7
The Impact of Polypharmacy on Management of Lower Urinary Tract Symptoms in Parkinson's Disease.多药治疗对帕金森病下尿路症状管理的影响。
Drugs Aging. 2023 Oct;40(10):909-917. doi: 10.1007/s40266-023-01060-2. Epub 2023 Aug 31.
8
Nocturia and Sleep in Parkinson's Disease.帕金森病中的夜尿症与睡眠
J Pers Med. 2023 Jun 27;13(7):1053. doi: 10.3390/jpm13071053.
9
Circadian disruption and sleep disorders in neurodegeneration.神经退行性疾病中的昼夜节律紊乱和睡眠障碍。
Transl Neurodegener. 2023 Feb 13;12(1):8. doi: 10.1186/s40035-023-00340-6.
10
Identifying Parkinson's disease subtypes with motor and non-motor symptoms via model-based multi-partition clustering.基于模型的多分区聚类识别具有运动和非运动症状的帕金森病亚型。
Sci Rep. 2021 Dec 8;11(1):23645. doi: 10.1038/s41598-021-03118-w.

本文引用的文献

1
Nocturia in Patients With Parkinson's Disease.帕金森病患者的夜尿症
Mov Disord Clin Pract. 2015 Dec 24;3(2):168-172. doi: 10.1002/mdc3.12279. eCollection 2016 Mar-Apr.
2
Mineralocorticoid Receptor Activation Contributes to the Supine Hypertension of Autonomic Failure.盐皮质激素受体激活导致自主神经功能衰竭患者的卧位高血压。
Hypertension. 2016 Feb;67(2):424-9. doi: 10.1161/HYPERTENSIONAHA.115.06617. Epub 2015 Dec 7.
3
Clinical characteristics of supine hypertension in de novo Parkinson disease.新发帕金森病患者仰卧位高血压的临床特征。
Clin Auton Res. 2016 Feb;26(1):15-21. doi: 10.1007/s10286-015-0324-8. Epub 2015 Nov 27.
4
Nocturia in Patients With Sleep-Disordered Breathing and Cardiovascular Disease.睡眠呼吸障碍与心血管疾病患者的夜尿症
Circ J. 2015;79(12):2632-40. doi: 10.1253/circj.CJ-15-0654. Epub 2015 Oct 19.
5
Lower urinary tract dysfunction in the neurological patient: clinical assessment and management.神经系统疾病患者的下尿路功能障碍:临床评估与管理。
Lancet Neurol. 2015 Jul;14(7):720-32. doi: 10.1016/S1474-4422(15)00070-8.
6
[Is nocturnal polyuria more frequent among patients with Parkinson's disease?].[帕金森病患者夜间多尿是否更常见?]
Prog Urol. 2015 May;25(6):312-7. doi: 10.1016/j.purol.2015.02.004. Epub 2015 Apr 3.
7
Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease.琥珀酸索利那新用于帕金森病膀胱过度活动症的随机对照试验性研究
Parkinsonism Relat Disord. 2015 May;21(5):514-20. doi: 10.1016/j.parkreldis.2015.02.025. Epub 2015 Mar 6.
8
A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders.帕金森病及其他步态障碍中膀胱功能障碍的管理指南。
Neurourol Urodyn. 2016 Jun;35(5):551-63. doi: 10.1002/nau.22764. Epub 2015 Mar 25.
9
Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease.确定帕金森病管理十大研究重点的优先事项设定伙伴关系。
BMJ Open. 2014 Dec 14;4(12):e006434. doi: 10.1136/bmjopen-2014-006434.
10
Sleep and circadian rhythm regulation in early Parkinson disease.早期帕金森病的睡眠和昼夜节律调节。
JAMA Neurol. 2014 May;71(5):589-595. doi: 10.1001/jamaneurol.2014.65.

帕金森病中的夜尿症:为何会发生以及如何处理?

Nocturia in Parkinson's Disease: Why Does It Occur and How to Manage?

作者信息

Batla Amit, Phé Véronique, De Min Lorenzo, Panicker Jalesh N

机构信息

Department of Motor neuroscience and Movement Disorders UCL Institute of Neurology London United Kingdom.

Department of Uro-Neurology The National Hospital for Neurology and Neurosurgery and UCL Institute of Neurology London United Kingdom.

出版信息

Mov Disord Clin Pract. 2016 Jun 7;3(5):443-451. doi: 10.1002/mdc3.12374. eCollection 2016 Sep-Oct.

DOI:10.1002/mdc3.12374
PMID:30363512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6178648/
Abstract

BACKGROUND

Nocturia is one of the commonest nonmotor symptoms in Parkinson's disease (PD) and has a significant impact on quality of life both for patients and their carers. There exists a relation between nocturia and poor sleep quality, falls, and institutionalization. Nocturia may manifest as a result of reduced functional bladder capacity or nocturnal polyuria; however, most often the cause is multifactorial. Disorders of circadian rhythm regulation are known to occur with sleep disturbances in PD may also contribute to nocturia.

METHODS AND RESULTS

In this review, an overview of the assessment and management of nocturia in patients with PD is presented. History taking, medication review, and a bladder diary form the cornerstone of the evaluation. Urinalysis, ultrasonography, and urodynamic studies help to assess the cause for lower urinary tract symptoms and exclude concomitant pathologies, such as bladder outlet obstruction. Antimuscarinic medications are the first-line treatment for the overactive bladder; however, caution is needed when using these medications in individuals predisposed to cognitive impairment. Desmopressin is effective for managing nocturnal polyuria.

CONCLUSIONS

An individualized approach is recommended to optimize the management of nocturia in PD.

摘要

背景

夜尿症是帕金森病(PD)最常见的非运动症状之一,对患者及其照料者的生活质量有重大影响。夜尿症与睡眠质量差、跌倒及入住养老院存在关联。夜尿症可能是由于膀胱功能容量降低或夜间多尿所致;然而,其原因通常是多因素的。已知昼夜节律调节紊乱会伴随PD患者的睡眠障碍出现,这也可能导致夜尿症。

方法与结果

在本综述中,对PD患者夜尿症的评估与管理进行了概述。病史采集、药物审查和膀胱日记是评估的基石。尿液分析、超声检查和尿动力学研究有助于评估下尿路症状的原因,并排除诸如膀胱出口梗阻等伴随疾病。抗胆碱能药物是治疗膀胱过度活动症的一线药物;然而,在易发生认知障碍的个体中使用这些药物时需谨慎。去氨加压素对治疗夜间多尿有效。

结论

建议采用个体化方法优化PD患者夜尿症的管理。